Detrimental Role of miRNA-144-3p in Intracerebral Hemorrhage Induced Secondary Brain Injury is Mediated by Formyl Peptide Receptor 2 Downregulation Both
apoptosis
formyl peptide receptor 2
intracerebral hemorrhage
microRNA-144-3p
Journal
Cell transplantation
ISSN: 1555-3892
Titre abrégé: Cell Transplant
Pays: United States
ID NLM: 9208854
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
pubmed:
5
12
2018
medline:
11
8
2020
entrez:
5
12
2018
Statut:
ppublish
Résumé
Although microRNA-144-3p (miRNA-144-3p) has been shown to suppress tumor proliferation and invasion, its function in intracerebral hemorrhage (ICH)-induced secondary brain injury (SBI) remains unclear. Thus, this study was designed to investigate the role of miRNA-144-3p in ICH. To accomplish this, we used adult male Sprague-Dawley rats to establish an
Identifiants
pubmed: 30511586
doi: 10.1177/0963689718817219
pmc: PMC6686441
doi:
Substances chimiques
MIRN144 microRNA, rat
0
MicroRNAs
0
Receptors, Lipoxin
0
lipoxin A(4) receptor, rat
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
723-738Références
Nat Med. 2001 Mar;7(3):338-43
pubmed: 11231633
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Eur J Pharmacol. 2005 Oct 17;522(1-3):30-7
pubmed: 16213482
Pharmacol Rev. 2006 Sep;58(3):463-87
pubmed: 16968948
Br J Pharmacol. 2008 Mar;153 Suppl 1:S200-15
pubmed: 17965751
Exp Neurol. 2009 Mar;216(1):35-46
pubmed: 19073180
Hippokratia. 2010 Oct;14(4):236-40
pubmed: 21311629
World J Neurosci. 2012 May 29;2(2):74-80
pubmed: 23482588
Int J Mol Sci. 2013 Apr 02;14(4):7193-230
pubmed: 23549262
Lancet. 2013 Aug 3;382(9890):397-408
pubmed: 23726393
PLoS One. 2013 Sep 16;8(9):e74175
pubmed: 24066116
Endocrine. 2015 Mar;48(2):566-74
pubmed: 24968735
Transl Stroke Res. 2015 Feb;6(1):4-8
pubmed: 25533878
FASEB J. 2015 May;29(5):2161-71
pubmed: 25690650
Circ Res. 2015 Feb 27;116(5):774-7
pubmed: 25722438
Transl Stroke Res. 2015 Aug;6(4):257-63
pubmed: 26073700
Crit Care Med. 2015 Sep;43(9):e369-81
pubmed: 26132882
Stroke. 2015 Sep;46(9):2607-15
pubmed: 26219651
Tumour Biol. 2015 Nov 13;:null
pubmed: 26566625
Biotechnol Lett. 2016 Mar;38(3):409-16
pubmed: 26687302
Stroke. 2016 Feb;47(2):490-7
pubmed: 26732571
Transl Stroke Res. 2016 Jun;7(3):192-208
pubmed: 26743212
Development. 2016 Mar 15;143(6):936-49
pubmed: 26893347
Sci Rep. 2016 Mar 30;6:23817
pubmed: 27026509
Circulation. 2016 May 31;133(22):2169-79
pubmed: 27154726
Neurochem Res. 2016 Oct;41(10):2627-2635
pubmed: 27300700
Cell Transplant. 2017 Jan 24;26(1):145-156
pubmed: 27535166
J Cereb Blood Flow Metab. 2017 Jul;37(7):2509-2525
pubmed: 27634935
Transl Stroke Res. 2017 Apr;8(2):183-193
pubmed: 27807801
Transl Stroke Res. 2017 Aug;8(4):307-317
pubmed: 28039575
Cell Transplant. 2017 Mar 13;26(3):395-407
pubmed: 28195036
Sci Rep. 2017 Mar 16;7(1):206
pubmed: 28303030
Cell Physiol Biochem. 2017;42(1):137-144
pubmed: 28505619
Circ Res. 2017 Jul 21;121(3):244-257
pubmed: 28522438
Am J Transl Res. 2017 May 15;9(5):2437-2446
pubmed: 28559994
PLoS One. 2017 Jun 21;12(6):e0179772
pubmed: 28636635
Transl Stroke Res. 2018 Feb;9(1):74-91
pubmed: 28766251
Oncol Rep. 2017 Oct;38(4):2173-2181
pubmed: 28849156
Cell Physiol Biochem. 2017;43(6):2420-2433
pubmed: 29073615
PLoS One. 2017 Nov 15;12(11):e0186520
pubmed: 29140979
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):95-100
pubmed: 29364475
J Biochem Mol Toxicol. 2018 Apr;32(4):e22044
pubmed: 29457851
Mol Cancer. 2018 Feb 22;17(1):64
pubmed: 29471827
Cell Transplant. 2018 Dec;27(12):1778-1788
pubmed: 29871520
Cell Transplant. 2018 Dec;27(12):1809-1824
pubmed: 29871521
Stroke. 1995 Apr;26(4):627-34; discussion 635
pubmed: 7709410
Cytometry. 1997 Jan 1;27(1):1-20
pubmed: 9000580